AdipoPharma SAS is clinical stage biotech dedicated to treat insulin resistance by targeting the adipocyte
AdipoPharma has raised $10.6M in total funding. The most recent round was Series A. The last funding was announced in November 2024.
AdipoPharma's investors include Good Growth Capital, Okeanos, Newton Biocapital, Sambrinvest, InvestSud.
AdipoPharma is headquartered in Strasbourg, France.
AdipoPharma SAS is clinical stage biotech dedicated to treat insulin resistance by targeting the adipocyte
AdipoPharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AdipoPharma — Funding & Investors." VCBacked, November 11, 2024, https://www.vcbacked.co/company/adipopharma. Accessed September 30, 2026.
VCBacked. (2024). AdipoPharma — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/adipopharma
{{cite web |title=AdipoPharma — Funding & Investors |url=https://www.vcbacked.co/company/adipopharma |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated